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Abstract: (Word count 149) 
Wheezing is common in childhood. However, current prediction models of paediatric asthma 
have only modest accuracy. Novel biomarkers and definition of subphenotypes may improve 
asthma prediction. Interleukin-1-receptor-Like-1 is a well-replicated asthma-gene and 
associates with eosinophilia. We investigated whether serum sST2 predicts asthma and 
asthma with elevated exhaled NO (FeNO), compared to the commonly used Asthma 
Prediction Index (API). Using logistic regression modeling, we found that serum sST2 levels 
in 2-3y old wheezers do not predict doctors’ diagnosed asthma at age 6y. Instead sST2 
predicts a subphenotype of asthma characterized by increased levels of FeNO, a marker for 
eosinophilic airway inflammation. Herein, sST2 improved the predictive value of the API 
(AUC=0.70, 95CI 0.56-0.84), but had also significant predictive value on its own (AUC=0.65, 
95CI 0.52-0.79). Our study indicates that sST2 in preschool wheezers has predictive value 
for the development of eosinophilic airway inflammation in asthmatic children at school age. 
 
Keywords: childhood asthma, fraction of exhaled NO, prediction, preschool wheezers, 
serum sST2 
 
List of Abbreviations: ADEM study: Asthma DEtection and Monitoring study; API: Asthma 
Prediction Index; FeNO: Fraction of exhaled Nitric Oxide; IL-1RL1: Interleukin-1 Receptor 
Like 1; PIAMA study: Prevalence and Incidence of Asthma and Mite Allergy study; SNP: 
Single Nucleotide Polymorphism; y=years. 
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To the editor: 
 
Approximately 40% of all preschool children (aged <6 years [y]) encounter one or more 
episodes of respiratory symptoms, such as wheezing, coughing and dyspnoea. However, 
only some (20-40%) of these preschool children with respiratory problems will develop 
asthma at school age.1 Current prediction models such as the asthma prediction index [API] 
are based on familiar predisposition, history of eczema, and presence of eosinophils or 
sensitization, and have only modest accuracy in predicting asthma.[1,2] To enable better 
prediction of asthma development at young age, novel biomarkers associated with asthma 
are required, which could include expression levels of well replicated asthma genes.[2]  
 
One potential biomarker for asthma is soluble Interleukin-1-receptor-like1 [IL-1RL1-a or 
sST2], which is encoded by the IL1RL1 gene (chr 2) and can be detected in serum. IL1RL1 
is an asthma susceptibility gene identified in genetic studies of paediatric and adult asthma 
patients.[3] IL1RL1 has also been linked to blood eosinophilia, IgE (sensitization), eczema 
and hay fever.[3,4] ST2 is the receptor for interleukin-33 (IL-33), a cytokine thought to initiate 
and amplify a Th-type-2 response in inflammatory diseases such as asthma.[5] Soluble ST2 
has been proposed to act as a decoy receptor, sequestering IL-33, thereby preventing its 
role in the induction of an immune response, and particularly its modulation of a Th-type-2 
reaction.[5,6]  
Previously, we found that IL1RL1 SNPs associate with sST2 levels in childhood asthma in a 
Dutch birth cohort, the Prevalence and Incidence of Asthma and Mite Allergy [PIAMA] cohort. 
In this study, asthma-risk alleles were consistently associated with lower serum sST2 levels, 
indicating a putative protective effect of high sST2.[7] Moreover, IL1RL1 SNPs were 
associated with intermediate onset and late onset wheezing phenotypes.[8] These children 
start to wheeze at age 2-3y, often have allergen sensitization at age 4y, and are at high risk 
of subsequent asthma development at school age. However, the expression levels of IL1RL1 
in preschool wheezers are unknown, as well as whether these levels could identify those 
children who will eventually develop asthma.  
 
Therefore, we hypothesized that serum sST2 levels measured in wheezing preschool 
children contribute to the prediction of asthma at school age. Moreover, since IL1RL1 was 
previously associated with blood eosinophilia, our second aim was to determine whether 
serum sST2 levels predict exhaled NO, as a marker of eosinophilic asthma at school age.  
 
We investigated our hypotheses in children of the ADEM [Asthma DEtection and Monitoring] 
study (clinicaltrial.gov: NCT 00422747). The ADEM study is a unique longitudinal cohort 
designed to study the added value of biomarkers to clinical information (API) for an early 
asthma diagnosis. A detailed study protocol has been published previously.[9] This study 
included 202 wheezing children and 50 healthy controls who were enrolled from primary care 
practices in The Netherlands at age 2-3y and were followed up annually until age 6y. At age 
6y, a final asthma diagnosis was made based on symptoms, use of asthma medication and 
lung function by experienced pediatricians in the field of respiratory medicine and by a 
computer algorithm. Corticosteroids were stopped 4 weeks before measurements when 
applicable. Wheezing at preschool age was defined as two or more wheezing episodes 
before inclusion, according to the questionnaire developed by the International Study of 
Asthma and Allergies in Childhood. sST2 serum levels at age 2-3y were quantified using a 
commercially available ELISA (R&D Systems Quantikine ELISA kit #DST200, Abingdon, 
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UK), which was selected after a series of validation steps comparing specificity, sensitivity, 
assay recovery and inter-assay variability (see also Supplemental Methods). 
For the current study, in analogy to earlier analyses of the ADEM study [2], a logistic 
regression model was built to predict asthma diagnosis at age 6y comparing the API, sST2 
and sST2 combined with API as predictors. Model performance was assessed by testing the 
contribution of a predictor to the model (F-test) and by quantifying discrimination (Area Under 
the Curve, AUC) using a receiver operating characteristics (ROC) curve. In the ADEM 
cohort, 40% of the preschool wheezers developed asthma at age 6y, while the remainder 
were transient wheezers. Predictive analyses were performed in the group with available 
sST2 levels at age 2-3y, which were 171 out of the 202 preschool wheezers. The subgroup 
of children with available sST2 serum levels did not significantly differ from the overall group 
in general characteristics. sST2 levels were square root transformed to meet normality 
criteria. 
A negative association was found between IL1RL1 genotype (using rs1420101, representing 
a major LD block in IL1RL1 [3]) and sST2 protein expression in serum (ANOVA P<0.001). 
Carriers of the asthma-risk allele (A) had lower sST2 levels, which is in the same direction as 
previously reported in the PIAMA cohort.[7]  
However, serum levels of sST2 measured at age 2-3y could not distinguish which of the 
preschool wheezing children eventually developed asthma at school age (AUC=0.50 [95CI 
0.41-0.59, P=0.98], B=-0.002 [OR=0.998, P=0.89]). No difference in serum sST2 levels at 
age 2-3y was found between children with transient wheeze, true asthmatics or healthy 
controls at age 6y (P=0.881, ANOVA). Consequently, serum sST2 levels at 2-3y did not 
significantly add to the prediction of an asthma diagnosis of the commonly used API (API 
alone: AUC= 0.60 [95CI 0.52-0.68, P=0.02]; API+IL1-RL1-a: AUC= 0.57 [95CI 0.49-0.66, 
P=0.12]). These results show that, although IL1RL1 SNPs may affect IL1RL1 expression 
levels, serum sST2 levels in wheezing children at 2-3y do not have added value in the 
prediction of doctors’ diagnosed asthma as general phenotype at school age. 
 
Possible reasons for this finding is the heterogeneity of the asthma phenotype in childhood, 
or the fact that our cohort of children was derived from a primary care setting, likely leading 
to an a priori lower asthma risk compared to a hospital setting. Since sST2 serum levels had 
previously been associated with blood eosinophil numbers in childhood asthma [10], we 
hypothesized that sST2 levels at 2-3y may predict measures of eosinophilic asthma rather 
than a general diagnosis of asthma at school age. In the ADEM cohort, levels of nitric oxide 
in exhaled breath (FeNO), considered a surrogate marker of eosinophilic airway inflammation 
in asthma patients [11], were measured at 6y (NIOX®; Aerocrine, Solna, Sweden). 
Interestingly, we found that serum levels of sST2 measured at age 2-3y, although modestly, 
were negatively correlated with FeNO levels at 6y in children who had developed asthma 
(Pearson’s R=-0.24, P= 0.046, N=59), while no significant correlation was observed in 
transient wheezers (Pearson’s R=0.08, P=0.47, N=89), see figure 1.This suggests that 
serum levels of sST2 at preschool age predict increased FeNO levels as a marker of 
eosinophilic airway inflammation in those children who will develop asthma. To investigate 
whether sST2 levels indeed could be a predictive biomarker for asthma with elevated FeNO 
levels, we next divided our population of asthmatic children at age 6y into a group with likely 
eosinophilic airway inflammation (FeNO≥20ppb, n=15) and asthmatics unlikely to have 
eosinophilic airway inflammation (FeNO<20ppb, n=60), based on the ATS guideline of 
FeNO.[11] We then performed logistic predictive modeling of asthma with elevated FeNO 
(Y/N) in wheezing children. Indeed, sST2 serum levels negatively predicted asthma with high 
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FeNO in preschool wheezers (OR=0.96, P=0.04, figure 2A/B), having a predicted AUC of 
0.65 (95CI 0.52-0.79). When sST2 serum levels were combined with the API, the predictive 
model slightly, and significantly improved to distinguish preschool wheezers who developed 
asthma with elevated FeNO at school age (predicted AUC of 0.70, 95CI 0.56-0.84). We 
acknowledge that the sample size of the group with likely eosinophilic airway inflammation at 
age 6y (FeNO ≥ 20ppb) of this analysis is limited, and propose that our findings should be 
replicated in future studies with larger sample size.  
FeNO levels in 2-3y old wheezers did not have predictive value for FeNO at school age in 
our cohort (data not shown), nor for asthma development.[12] Moreover, although FeNO 
levels have previously been found useful in prediction of management of established asthma 
[13,14], FeNO could not predict treatment response in preschool wheezers.[15] . 
 
Given the timespan (three to four years) between the measurement of sST2 and FeNO, and 
the negative correlation, it is tempting to speculate that sST2 levels could have a protective 
effect on the development of eosinophilic airway inflammation in asthmatic children. 
However, no data on eosinophil counts were available in the current cohort to further study 
this relationship. Nevertheless, in a previous study an inverse relationship between sST2 
levels and blood eosinophil counts has been reported during exacerbations of childhood 
asthma.[10] Further evidence indicating a potential protective effect of sST2 in (eosinophilic) 
asthma are more experimental (murine) model studies of asthma, wherein delivering sST2 
(respectively intraperitoneally/intranasally) significantly decreased inflammatory airway 
disease, including reduced eosinophil counts in BAL and methacholine induced airway 
hyperresponsiveness.[16,17] That a protective effect of sST2 might be rather disease 
specific is indicated by findings that sST2 levels positively predict other conditions, including 
mortality in cardiovascular disease [18,19] and disease activity in autoimmune diseases such 
as juvenile arthritis.[20] 
 
In summary, we show that sST2 serum levels in preschool wheezers do not add to the 
prediction of doctors’ diagnosed asthma as general phenotype at school age. However, sST2 
serum levels at age 2-3y inversely correlate with FeNO levels in asthmatic children at 6y. 
Likewise, IL1-RL1-a serum levels in preschool wheezers contributed to the prediction of a 
subtype of asthma with elevated FeNO at age 6y, showing a negative direction of effect. 
Therefore, our study indicates that sST2 might play a protective role in the development of 
eosinophilic airway inflammation in children who experience asthma at school age. Our 
findings suggest that sST2 has potential to be further explored as a biomarker in wheezing 
children to predict the development of asthma with predominant eosinophilic inflammation. A 
combination of several markers is likely necessary to accurately predict asthma on an 
individual level. So far exhaled volatile organic compounds demonstrated great potential for 
the prediction of asthma at age 6y.[2] Furthermore, in future biomarker studies investigating 
the role of IL-1RL1-a, other measures likely relevant in the development of eosinophilic 
inflammation should be considered, including sputum and blood eosinophil counts. 
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Figure 1- Correlation of sST2 serum levels (2-3y) and FeNO (6y). sST2 serum levels 
measured in wheezers at age 2-3y negatively correlate with fraction of exhaled nitric oxide 
levels (FeNO, online method) in children who have developed asthma at age 6y. Boxplots 
show the quartiles and outliers of the distribution of sST2 (x-axis) and FeNO (y-axis). 
ppb=parts per billion. 
  





Figure 2- Prediction of asthma with elevated FeNO in childhood using sST2 serum levels and the API  
A- Receiver Operating Characteristics (ROC) curve comparing the predictive value of serum sST2 levels, the 
Asthma Prediction Index (API), and their combined predictive value for development of childhood asthma with 
FeNO≥20ppb to the Reference Line (representing the 0-hypothesis of a predicted area under the curve (AUC)= 
0.5).  
  





Figure 2- Prediction of asthma with elevated FeNO in childhood using sST2 serum levels and the API 
B- Calculations of the AUC and parameters of the logistic regression model of the prediction of asthma with 
FeNO≥20ppb. sST2 serum levels at in 2-3y old wheezers (n=171) significantly predict this eosinophilic subtype 
of asthma at age 6y (n=15, P=0.04) with an average AUC of 0.65 (95CI 0.52-0.79, P=0.059). The combined 
logistic model of API+sST2 serum levels has an average AUC of 0.70 (95CI 0.56-0.84, P=0.01). 
API: Asthma Prediction Index (based on parental asthma, eczema, allergic rhinitis, wheezing apart from cold, 
atopy as determined by Phadiatop). Pred AUC: predicted area under the curve. 95CI: 95% confidence interval. B: 
regression coefficient. NPV=negative predicitve value. OR: Odds Ratio. PPV=positive predictive value. 
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M.E. Ketelaar et al.   
Serum IL-1RL1-a levels predict exhaled NO levels in preschool wheezers who develop 
asthma 
 
Supplemental Materials and Method: 
 
Study descriptives  
The Asthma DEtection and Monitoring [ADEM] study (clinicaltrial.gov: NCT 00422747)[9] is a 
longitudinal prospective study, aimed to develop an instrument to diagnose asthma at early 
age, by using biomarkers of airway inflammation. In total, 202 wheezing children and 50 non-
wheezing children (healthy controls) were prospectively followed from the age of 2-3y until 
6y. Wheezing was defined as two or more wheezing episodes before inclusion, according to 
the questionnaire developed by the International Study of Asthma and Allergies in Childhood 
[ISAAC].[9] Four wheezing children were lost during follow-up due to personal constraints of 
the parents. One child in the control group was diagnosed with asthma at age 6y. The study 
design of the ADEM cohort has been published before.[9] For the current study, serum levels 
of soluble Interleukin-1-receptor-like1 (IL-1RL1-a) were studied in the context of the 
commonly used asthma prediction index [API].[2,9] In total,171 wheezing children and 39 
controls had IL-1RL1 measures available and a diagnosis at age 6y. These groups did not 
significantly differ from the total population.  
 
Asthma diagnosis 
At the age of 6y, a diagnosis of ‘healthy’ (=never-wheezer), ‘transient wheezer’ (=wheezing 
before or at preschool age, but no asthma symptoms at age 6y), or ‘true asthmatic’ was 
made by an experienced pediatrician in the field of respiratory medicine. This was based on 
symptoms, lung function (reversibility to a beta-2-agonist and bronchial 
hyperresponsiveness) and medication use. In addition, this clinical diagnosis was assessed 
by a computer-calculated algorithm as described previously.[9] Non-invasive measures of 
asthma were determined at age 6y, including fraction of exhaled nitric oxide (FeNO). FeNO 
was measured using the online method (NIOX®; Aerocrine, Solna, Sweden) as published 
previously.[2,9] 
Asthma with elevated FeNO was defined as asthma with FeNO>20ppb (n=15), representing 
a group of asthmatic children with intermediate to high level of eosinophilic airway 
inflammation, following the ATS guide for interpretation of FeNO.[11] The group of asthmatic 
children with FeNO>20ppb represented the upper quartile of FeNO in the current cohort.  
 
Asthma prediction measures, determination of IL-1RL1-a protein and IL1RL1 genotype  
Asthma prediction index (API) was assessed based on parental asthma, eczema, allergic 
rhinitis, wheezing apart from cold, and atopy. Besides atopy, variables were reported by 
questionaires.[2,9] A positive score on atopy was determined by a specific IgE concentration 
against a mixture of inhalant and food allergies (Phadiatop infant test, Phadia, Uppsala, 
Sweden) of ≥ 0.35 kU/L determined at inclusion.[2]  
IL-1RL1-a protein levels were determined in serum at inclusion (age 2-3y) using ELISA (IL-
1RL1 human Quantikine kit R&D Systems®, Abingdon, United Kingdom). Considering the 
importance of validating this type of immuno-assays for use in serum/plasma samples, as 
also highlighted by Nygaard et al (2016)[4], and seen for IL-33 ourselves[S1], the assay was 
validated for specificity, sensitivity, assay recovery and inter-assay variability using a spiking 
approach with serum, serial dilutions, freeze/thaw experiments, and reproducibility testing on 
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separate plates/days. We have tested three kits (R&D DuoSet sST2 ELISA kit, # DY523B, 
R&D Quantikine ELISA kit #DST200 and MBL sST2 ELISA kit #7638), out of which the R&D 
Quantikine ELISA was selected for use in the current study, having the best overall 
performance. 
 
Statistical analysis:  
Analyses were done using SPSS Statistics 23 (IBM, Amsterdam, The Netherlands). ANOVA 
was used to compare serum IL-1RL1-a levels among groups, with Tukey’s post-hoc testing 
in case of P<0.05. In analogy to earlier analyses in the ADEM study [2], a logistic regression 
model was built to predict asthma diagnosis at age 6y using the API and/or serum protein 
levels of IL-1RL1-a at 2-3y as predictors. Pearson correlation was used to correlate IL-1RL1 
serum levels at age 2-3y with FeNO levels at age 6y. IL-1RL1-a serum values were square 
root transformed and FeNO levels natural log transformed to meet normality criteria. F-test 
was used to asses additive value of a predictor to the model, with statistical significance at 
P<0.05. The model performance was further investigated by quantifying discrimination (Area 
Under the Curve, AUC) using a receiver operating characteristics (ROC) curve, plotting 
sensitivity and 1-specificity. Herein, model performance was assessed compared to the 
Reference Line, representing a predicted AUC of 0.5. 
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